Prasad Raju
SEC CIK 1968317 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | CFO | 14.8K | — | $5.60M | 17 | 2024-03-14 | 2026-08-07 |
Most active insiders at CRSP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kulkarni Samarth | CEO, Dir | — | $10.76M |
| 2 | Prasad Raju | CFO | — | $5.10M |
| 3 | KASINGER JAMES R. | GC, Sec | — | $1.27M |
| 4 | Behbahani Ali | Dir | — | $780.9K |
| 5 | Patel Naimish | Chief Medical Off | — | $362.6K |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 17:35 | 2026-08-07 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | G - Gift | $0.00 | -750 | 14.8K | -5% | $0 | |
| D | 2026-03-24 | 2026-03-20 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | M - OptEx | — | +6,250 | 19.3K | +48% | — |
| D | 2026-03-24 | 2026-03-23 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | S - Sale+OE | $46.78 | -3,708 | 15.6K | -19% | -$173.5K |
| DM | 2026-03-17 | 2026-03-16 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | S - Sale+OE | $48.26 | -9,869 | 13.8K | -42% | -$476.3K |
| D | 2026-03-17 | 2026-03-16 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | G - Gift | $0.00 | -750 | 13.0K | -5% | $0 |
| DM | 2026-03-17 | 2026-03-14 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | M - OptEx | — | +16.9K | 16.8K | New | — |
| DT | 2026-01-26 | 2026-01-22 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | M - OptEx | $45.15 | +35.0K | 41.7K | +517% | +$1.58M |
| DT | 2026-01-26 | 2026-01-22 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | S - Sale+OE | $60.19 | -35.0K | 6,767 | -84% | -$2.10M |
| DMT | 2026-01-08 | 2026-01-06 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | M - OptEx | $44.97 | +29.7K | 36.5K | +439% | +$1.34M |
| DMT | 2026-01-08 | 2026-01-06 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | S - Sale+OE | $60.16 | -29.7K | 17.5K | -63% | -$1.79M |
| MT | 2025-12-23 | 2025-12-22 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | S - Sale | $55.95 | -10.0K | 7,767 | -56% | -$559.5K |
| D | 2025-03-24 | 2025-03-20 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | M - OptEx | — | +6,250 | 19.0K | +49% | — |
| D | 2025-03-24 | 2025-03-21 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | S - Sale+OE | $41.23 | -2,197 | 16.8K | -12% | -$90.6K |
| D | 2025-03-18 | 2025-03-17 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | S - Sale+OE | $41.80 | -3,762 | 12.7K | -23% | -$157.3K |
| D | 2025-03-18 | 2025-03-14 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | M - OptEx | — | +10.0K | 16.5K | +154% | — |
| D | 2024-03-18 | 2024-03-14 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | M - OptEx | — | +10.0K | 10.0K | New | — |
| D | 2024-03-18 | 2024-03-15 | CRSP | CRISPR Therapeutics AG | Prasad Raju | CFO | S - Sale+OE | $72.69 | -3,524 | 6,476 | -35% | -$256.2K |
Purchase Sale Sale after option exercise All abbreviations